SCHEMBL3213306

SCHEMBL3213306

CCN(CC)C(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27540624 0.96
Ammonia Solution, Strong SCHEMBL29251169 0.96
Hydrochloric Acid SCHEMBL28140767 0.93 FDPS (0.32)
SCHEMBL26230557 0.77 FDPS (0.35)
SCHEMBL1776275 0.74
SCHEMBL335809 0.74
Bromide SCHEMBL11873099 0.72
Hydrochloric Acid SCHEMBL216404 0.72
SCHEMBL19881955 0.72
SCHEMBL2102047 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2440 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152742-A Polymer with dual therapeutic agents 索尼集团公司 2025-06-13 CN claimed
CN-119997963-A Combination therapy of lactobacillus plantarum strains and cancer treatment method using same 南韩商GI生物群系公司 2025-05-13 CN claimed
CN-119731151-A Novel cinnamide derivative and use thereof 韩国生命工学研究院 2025-03-28 CN claimed
CN-119591582-A Imide-based proteolytic modulators and related methods of use 阿尔维纳斯运营股份有限公司 2025-03-11 CN claimed
CN-119431581-A Antigen binding proteins 葛兰素史密斯克莱知识产权发展有限公司 2025-02-14 CN claimed
CN-113710668-B Condensed azines for EP300 or CBP modulation and indications thereof OPNA生物公司 2025-01-07 CN claimed
CN-118878694-A Bispecific antibody and application thereof 康诺亚生物医药科技(成都)有限公司 2024-11-01 CN claimed
CN-118878693-A Bispecific antibody and application thereof 康诺亚生物医药科技(成都)有限公司 2024-11-01 CN claimed
CN-118660713-A Composition for preventing or treating cancer using combination therapy comprising lactobacillus plantarum strain and anticancer agent 南韩商GI生物群系公司 2024-09-17 CN claimed
CN-112062855-B Development and application of drug therapeutic agent containing adapter 北京天诺健成医药科技有限公司 2024-08-30 CN claimed
CN-100591336-C Extract of trapa natans and methods of using the same KIN-PING WONG 2010-02-24 CN claimed
US-20100036119-A1 FLUORINATING REAGENTS AND THEIR PREPARATION LANXESS DEUTSCHLAND GMBH (DE) 2010-02-11 US claimed
CN-100508961-C Compound medicine of GST activated anticancer compound and another anticancer therapy and pharmaceutical application TELIK INC (US) 2009-07-08 CN claimed
CN-1953762-A Sensitization to and/or amelioration of side effects of another anti-cancer therapy by treatment with a GST-activated anti-cancer compound TELIK INC (US) 2007-04-25 CN claimed
CN-1741806-A Pharmaceutical composition containing active substance extracted from fructus Lycii and its application WONG KIN PING (US) 2006-03-01 CN claimed
CN-1738634-A Extract of stephaniae sinica diels and methods of using the same WONG KIN PING (US) 2006-02-22 CN claimed
CN-1735419-A Extract of trapa natans and methods of using the same WONG KIN PING (US) 2006-02-15 CN claimed
CN-1711076-A Combination cancer therapy of a GST-activated anticancer compound and another anticancer therapy TELIK INC (US) 2005-12-21 CN claimed
US-20050085474-A1 Fluorinating reagents and their preparation LANXESS DEUTSCHLAND GMBH (DE) 2005-04-21 US claimed
EP-1437342-A2 Fluorinating reactants and process for their preparation Bayer Chemicals AG (DE) 2004-07-14 EP claimed